These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 20590578)

  • 1. A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells.
    Ford LA; Roelofs AJ; Anavi-Goffer S; Mowat L; Simpson DG; Irving AJ; Rogers MJ; Rajnicek AM; Ross RA
    Br J Pharmacol; 2010 Jun; 160(3):762-71. PubMed ID: 20590578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LPI/GPR55 axis enhances human breast cancer cell migration via HBXIP and p-MLC signaling.
    Zhou XL; Guo X; Song YP; Zhu CY; Zou W
    Acta Pharmacol Sin; 2018 Mar; 39(3):459-471. PubMed ID: 29188802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis.
    Kargl J; Andersen L; Hasenöhrl C; Feuersinger D; Stančić A; Fauland A; Magnes C; El-Heliebi A; Lax S; Uranitsch S; Haybaeck J; Heinemann A; Schicho R
    Br J Pharmacol; 2016 Jan; 173(1):142-54. PubMed ID: 26436760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells.
    Bondarenko A; Waldeck-Weiermair M; Naghdi S; Poteser M; Malli R; Graier WF
    Br J Pharmacol; 2010 Sep; 161(2):308-20. PubMed ID: 20735417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidylinositol Promotes Chemotaxis and Cytokine Synthesis in Mast Cells with Differential Participation of GPR55 and CB2 Receptors.
    Martínez-Aguilar LM; Ibarra-Sánchez A; Guerrero-Morán DJ; Macías-Silva M; Muñoz-Bello JO; Padilla A; Lizano M; González-Espinosa C
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-α-lysophosphatidylinositol meets GPR55: a deadly relationship.
    Ross RA
    Trends Pharmacol Sci; 2011 May; 32(5):265-9. PubMed ID: 21367464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity.
    Moreno-Navarrete JM; Catalán V; Whyte L; Díaz-Arteaga A; Vázquez-Martínez R; Rotellar F; Guzmán R; Gómez-Ambrosi J; Pulido MR; Russell WR; Imbernón M; Ross RA; Malagón MM; Dieguez C; Fernández-Real JM; Frühbeck G; Nogueiras R
    Diabetes; 2012 Feb; 61(2):281-91. PubMed ID: 22179809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis.
    Hofmann NA; Yang J; Trauger SA; Nakayama H; Huang L; Strunk D; Moses MA; Klagsbrun M; Bischoff J; Graier WF
    Br J Pharmacol; 2015 Aug; 172(16):4107-18. PubMed ID: 25989290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G protein-coupled receptor 55 ligand l-α-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion.
    Kallendrusch S; Kremzow S; Nowicki M; Grabiec U; Winkelmann R; Benz A; Kraft R; Bechmann I; Dehghani F; Koch M
    Glia; 2013 Nov; 61(11):1822-31. PubMed ID: 24038453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells.
    Oka S; Kimura S; Toshida T; Ota R; Yamashita A; Sugiura T
    J Biochem; 2010 May; 147(5):671-8. PubMed ID: 20051382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling.
    Calvillo-Robledo A; Cervantes-Villagrana RD; Morales P; Marichal-Cancino BA
    Life Sci; 2022 Jul; 301():120596. PubMed ID: 35500681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.
    Yamashita A; Oka S; Tanikawa T; Hayashi Y; Nemoto-Sasaki Y; Sugiura T
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():103-16. PubMed ID: 23714700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells.
    Obara Y; Ueno S; Yanagihata Y; Nakahata N
    PLoS One; 2011; 6(8):e24284. PubMed ID: 21904624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?
    Nevalainen T; Irving AJ
    Curr Top Med Chem; 2010; 10(8):799-813. PubMed ID: 20370712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.
    Anavi-Goffer S; Baillie G; Irving AJ; Gertsch J; Greig IR; Pertwee RG; Ross RA
    J Biol Chem; 2012 Jan; 287(1):91-104. PubMed ID: 22027819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation.
    Piñeiro R; Maffucci T; Falasca M
    Oncogene; 2011 Jan; 30(2):142-52. PubMed ID: 20838378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the lysophosphatidylinositol/GPR55 axis in cancer.
    Falasca M; Ferro R
    Adv Biol Regul; 2016 Jan; 60():88-93. PubMed ID: 26588872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.
    Henstridge CM; Balenga NA; Ford LA; Ross RA; Waldhoer M; Irving AJ
    FASEB J; 2009 Jan; 23(1):183-93. PubMed ID: 18757503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
    Chen M; Towers LN; O'Connor KL
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The GPR55 agonist lysophosphatidylinositol relaxes rat mesenteric resistance artery and induces Ca(2+) release in rat mesenteric artery endothelial cells.
    AlSuleimani YM; Hiley CR
    Br J Pharmacol; 2015 Jun; 172(12):3043-57. PubMed ID: 25652040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.